AB1128
Anti-Respiratory Syncytial Virus Antibody
Chemicon®, from goat
Synonym(s):
RSV
Sign Into View Organizational & Contract Pricing
All Photos(2)
About This Item
UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41
biological source
goat
Quality Level
antibody form
purified immunoglobulin
antibody product type
primary antibodies
clone
polyclonal
species reactivity
human
manufacturer/tradename
Chemicon®
technique(s)
ELISA: suitable
immunofluorescence: suitable
immunohistochemistry: suitable (paraffin)
shipped in
wet ice
Specificity
Recognizes RSV, all antigens. Does not react with Para 1-3, Influenza A & B and Adenovirus by IFA. Non reactive with HEp-2 cells and WI-38 cells.
Immunogen
Human RSV isolate
Application
Anti-Respiratory Syncytial Virus Antibody is an antibody against Respiratory Syncytial Virus for use in ELISA, IF, IH(P).
Indirect immunofluorescence: 1:480.
Reactive in paraffin embedded sections (see matsuse, et al 2000).
ELISA: 1:10,000
Fusion inhibition (1:256)
Optimal working dilutions must be determined by end user.
Reactive in paraffin embedded sections (see matsuse, et al 2000).
ELISA: 1:10,000
Fusion inhibition (1:256)
Optimal working dilutions must be determined by end user.
Physical form
Format: Purified
Purified immunoglobulin in PBS (0.01 M, pH 7.2) with 0.1% sodium azide.
Storage and Stability
Maintain -20°C in undiluted aliquots for up to 12 months. Avoid repeated freeze/thaw cycles.
Other Notes
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Not finding the right product?
Try our Product Selector Tool.
WGK
WGK 2
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Nanobodies? specific for respiratory syncytial virus fusion protein protect against infection by inhibition of fusion.
Schepens, B; Iba?ez, LI; De Baets, S; Hultberg, A; Bogaert, P; De Bleser, P; Vervalle et al.
The Journal of Infectious Diseases null
Recurrent respiratory syncytial virus infections in allergen-sensitized mice lead to persistent airway inflammation and hyperresponsiveness.
H Matsuse, A K Behera, M Kumar, H Rabb, R F Lockey, S S Mohapatra
Journal of immunology (Baltimore, Md. : 1950) (1950)
Protein kinase C-alpha activity is required for respiratory syncytial virus fusion to human bronchial epithelial cells.
San-Juan-Vergara, H; Peeples, ME; Lockey, RF; Mohapatra, SS
Journal of virology null
Respiratory syncytial virus (RSV) suppression of glucocorticoid receptor phosphorylation does not account for repression of transactivation.
Webster Marketon, JI; Corry, J
FEBS Open Bio null
Weidong Zhang et al.
Nature medicine, 11(1), 56-62 (2004-12-28)
Respiratory syncytial virus (RSV) infection is one of the major causes of respiratory tract infection for which no vaccine or antiviral treatment is available. The RSV NS1 protein seems to antagonize the host interferon (IFN) response; however, its mechanism is
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service